Commodore Capital LP Diversified Active

CIK: 0001831942 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value ($000): $447,722 (100.0% shares, 0.0% debt)

Holdings (27)

— MERUS N V 10.7%

Value ($000) $48,026 Shares 1,816,421 Est. Cost $26.99 Unrealized —

ACRS ACLARIS THERAPEUTICS INC 8.9%

Value ($000) $39,905 Shares 2,314,648 Est. Cost $12.93 Unrealized +5.5%

— BELLUS HEALTH INC NEW 8.7%

Value ($000) $38,787 Shares 5,637,630 Est. Cost $7.53 Unrealized —

— IVERIC BIO INC 8.3%

Value ($000) $37,278 Shares 2,214,961 Est. Cost $11.13 Unrealized —

XENE XENON PHARMACEUTICALS INC 8.2%

Value ($000) $36,764 Shares 1,202,613 Est. Cost $22.46 Unrealized +33.3%

CYTK CYTOKINETICS INC 7.0%

Value ($000) $31,460 Shares 854,652 Est. Cost $26.17 Unrealized +35.8%

— KARYOPHARM THERAPEUTICS INC 5.9%

Value ($000) $26,245 Shares 3,561,052 Est. Cost $7.37 Unrealized —

COGT COGENT BIOSCIENCES INC 5.9%

Value ($000) $26,221 Shares 3,500,768 Est. Cost $8.56 Unrealized -18.6%

— CYMABAY THERAPEUTICS INC 4.0%

Value ($000) $17,847 Shares 5,738,500 Est. Cost $4.40 Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 3.9%

Value ($000) $17,590 Shares 951,339 Est. Cost $16.71 Unrealized +15.0%

— TRICIDA INC 3.2%

Value ($000) $14,340 Shares 1,744,570 Est. Cost $9.18 Unrealized —

— SATSUMA PHARMACEUTICALS INC 3.1%

Value ($000) $14,103 Shares 3,711,286 Est. Cost $5.89 Unrealized —

— VISTAGEN THERAPEUTICS INC 2.8%

Value ($000) $12,521 Shares 10,097,229 Est. Cost $1.98 Unrealized —

KURA KURA ONCOLOGY INC 2.8%

Value ($000) $12,486 Shares 776,514 Est. Cost $14.44 Unrealized 0.0%

CCCC C4 THERAPEUTICS INC 2.6%

Value ($000) $11,671 Shares 481,094 Est. Cost $29.00 Unrealized -16.3%

IMUX IMMUNIC INC 2.3%

Value ($000) $10,091 Shares 893,013 Est. Cost $11.58 Unrealized 0.0%

CELC CELCUITY INC 1.9%

Value ($000) $8,606 Shares 920,464 Est. Cost $25.49 Unrealized -59.2%

CLDX CELLDEX THERAPEUTICS INC NEW 1.8%

Value ($000) $8,215 Shares 241,199 Est. Cost $31.97 Unrealized 0.0%

PTGX PROTAGONIST THERAPEUTICS INC 1.8%

Value ($000) $7,859 Shares 331,886 Est. Cost $32.91 Unrealized -14.4%

TNYA TENAYA THERAPEUTICS INC 1.4%

Value ($000) $6,054 Shares 513,930 Est. Cost $21.49 Unrealized -43.7%

KALV KALVISTA PHARMACEUTICALS INC 1.0%

Value ($000) $4,607 Shares 312,553 Est. Cost $24.62 Unrealized -41.6%

GNCAQ GENOCEA BIOSCIENCES INC 0.9%

Value ($000) $3,850 Shares 3,079,756 Est. Cost $2.51 Unrealized -56.6%

IVA INVENTIVA SA 0.7%

Value ($000) $2,994 Shares 262,658 Est. Cost $14.53 Unrealized —

DYN DYNE THERAPEUTICS INC 0.7%

Value ($000) $2,941 Shares 305,125 Est. Cost $19.35 Unrealized -56.0%

PMVP PMV PHARMACEUTICALS INC 0.6%

Value ($000) $2,603 Shares 125,000 Est. Cost $39.23 Unrealized -55.0%

— BCLS ACQUISITION CORP 0.6%

Value ($000) $2,468 Shares 250,000 Est. Cost $11.14 Unrealized —

MREO MEREO BIOPHARMA GROUP PLC 0.5%

Value ($000) $2,190 Shares 1,954,970 Est. Cost $3.56 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	MERUS N V	1,816,421	$48,026	10.7%	$26.99	—	COM	N5749R100
ACRS	ACLARIS THERAPEUTICS INC	2,314,648	$39,905	8.9%	$12.93	+5.5%	COM	00461U105
—	BELLUS HEALTH INC NEW	5,637,630	$38,787	8.7%	$7.53	—	COM NEW	07987C204
—	IVERIC BIO INC	2,214,961	$37,278	8.3%	$11.13	—	COM	46583P102
XENE	XENON PHARMACEUTICALS INC	1,202,613	$36,764	8.2%	$22.46	+33.3%	COM	98420N105
CYTK	CYTOKINETICS INC	854,652	$31,460	7.0%	$26.17	+35.8%	COM NEW	23282W605
—	KARYOPHARM THERAPEUTICS INC	3,561,052	$26,245	5.9%	$7.37	—	COM	48576U106
COGT	COGENT BIOSCIENCES INC	3,500,768	$26,221	5.9%	$8.56	-18.6%	COM	19240Q201
—	CYMABAY THERAPEUTICS INC	5,738,500	$17,847	4.0%	$4.40	—	COM	23257D103
VRDN	VIRIDIAN THERAPEUTICS INC	951,339	$17,590	3.9%	$16.71	+15.0%	COM	92790C104
—	TRICIDA INC	1,744,570	$14,340	3.2%	$9.18	—	COM	89610F101
—	SATSUMA PHARMACEUTICALS INC	3,711,286	$14,103	3.1%	$5.89	—	COM	80405P107
—	VISTAGEN THERAPEUTICS INC	10,097,229	$12,521	2.8%	$1.98	—	COM NEW	92840H202
KURA	KURA ONCOLOGY INC	776,514	$12,486	2.8%	$14.44	0.0%	COM	50127T109
CCCC	C4 THERAPEUTICS INC	481,094	$11,671	2.6%	$29.00	-16.3%	COM STK	12529R107
IMUX	IMMUNIC INC	893,013	$10,091	2.3%	$11.58	0.0%	COM	4525EP101
CELC	CELCUITY INC	920,464	$8,606	1.9%	$25.49	-59.2%	COM	15102K100
CLDX	CELLDEX THERAPEUTICS INC NEW	241,199	$8,215	1.8%	$31.97	0.0%	COM NEW	15117B202
PTGX	PROTAGONIST THERAPEUTICS INC	331,886	$7,859	1.8%	$32.91	-14.4%	COM	74366E102
TNYA	TENAYA THERAPEUTICS INC	513,930	$6,054	1.4%	$21.49	-43.7%	COM	87990A106
KALV	KALVISTA PHARMACEUTICALS INC	312,553	$4,607	1.0%	$24.62	-41.6%	COM	483497103
GNCAQ	GENOCEA BIOSCIENCES INC	3,079,756	$3,850	0.9%	$2.51	-56.6%	COM NEW	372427401
IVA	INVENTIVA SA	262,658	$2,994	0.7%	$14.53	—	ADS	46124U107
DYN	DYNE THERAPEUTICS INC	305,125	$2,941	0.7%	$19.35	-56.0%	COM	26818M108
PMVP	PMV PHARMACEUTICALS INC	125,000	$2,603	0.6%	$39.23	-55.0%	COM	69353Y103
—	BCLS ACQUISITION CORP	250,000	$2,468	0.6%	$11.14	—	COM CL A	G0904B105
MREO	MEREO BIOPHARMA GROUP PLC	1,954,970	$2,190	0.5%	$3.56	—	ADS	589492107